The US FDA’s Assessment Aid (AAid) pilot project resulted from a desire to reduce the amount of word processing oncology reviewers do as they analyze drug applications, but it also could spur a change in how FDA and sponsors put together briefing documents for advisory committee meetings.
[Sidebar#PS124267]







